Wegovy injection: Once-weekly semaglutide at a higher dose (up to 2.4mg) than Ozempic, approved for weight loss in adults and adolescents ages 12+
Its extensive research history has established DSIP as a recognised compound across multiple areas of peptide-focused investigation
Because a pharmaceutical company cant monetize it because theres no patent on it, so I dont know when were ever going to get the real truth on this thing, because nobodys putting billions of dollars into researching it, because nobodys going to monetize it
-Rare side effects such as weakness, mood swing, irritability, numbness or tingling
Ice crystal formation during freezing damages peptide structure
All these actions protect our brain and keep it healthy as we age